FindTrial
Sign In

Comparison of Hemodynamic effects during induction with Dexmedetomidine as an adjuvant to Propofol and Propofol as a sole agent patients undergoing elective surgeries under General anesthesia.

Comparison of Hemodynamic effects during induction with Dexmedetomidine as an adjuvant to Propofol and Propofol as a sole agent in patients undergoing elective surgeries under General anesthesia in a Tertiary Care Centre - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111472
Enrollment
38
Registered
2026-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E04- Other nontoxic goiter

Interventions

Intervention1: Dexmedetomidine with Propofol: Patients were given intravenous dexmedetomidine 0.5mcg/kg in 100 ml normal saline over 10 minutes initially, and then induction of anesthesia was done wit

Sponsors

SUT Academy of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who were between 18 to 60 years admitted for elective surgery, with an American Society of Anestheiologists(ASA) Grade I or II were included in this study.

Exclusion criteria

Exclusion criteria: Patients below 18 or above 60 years, those who denied consent, had an ASA Grade of III or IV, those known to have allergy to Propofol or dexmedetomidine or both, and patients with preexisting cardiorespiratory or liver diseases were excluded from this study.

Design outcomes

Primary

MeasureTime frame
To compare the hemodynamic effects of use of dexmedetomidine as an adjunct with propofol against propofol as sole agent for the induction phase of general anaesthesia in patients undergoing elective surgical procedures.Timepoint: Baseline , prior to induction, 1 min ,5mins 10 mins and 15 mins—

Secondary

MeasureTime frame
Comparison of amount of propofol needed in each patients of both the groupTimepoint: Baseline—

Countries

India

Contacts

Public ContactTania Jose

SUT Academy of Medical Sciences

anandbinumangal@gmail.com9645040196

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026